RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brazilian study aims to prove RSV shot for pregnant women shields newborns
⭐️ VACCINE ⭐️ Not yet recruitingThis study aims to measure how well a vaccine given to pregnant women protects their babies from severe Respiratory Syncytial Virus (RSV) illness during their first months of life. Researchers will follow 5000 infants in Brazil, comparing those whose mothers received the vaccine …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Sponsor: Inova Medical • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 04:11 UTC
-
New shot for babies aims to block dangerous RSV virus
Prevention Not yet recruitingThis study is testing a new injection called SIBP-A16 to see if it can help prevent serious illness from Respiratory Syncytial Virus (RSV) in infants. It will involve 36 premature and full-term babies under 1 year old who are entering their first RSV season. Researchers will give…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: Prevention
Last updated Apr 01, 2026 14:43 UTC